- Home
- NMRK vs VERA Comparison
NMRK vs VERA Comparison
Compare NMRK & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRK | VERA |
|---|---|---|
| Founded | 1929 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.0B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NMRK | VERA |
|---|---|---|
| Price | $15.40 | $42.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | $18.75 | ★ $81.30 |
| AVG Volume (30 Days) | 1.4M | ★ 2.1M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $3,294,024,000.00 | N/A |
| Revenue This Year | $12.45 | N/A |
| Revenue Next Year | $8.02 | $472.48 |
| P/E Ratio | $195.63 | ★ N/A |
| Revenue Growth | ★ 20.29 | N/A |
| 52 Week Low | $12.06 | $19.07 |
| 52 Week High | $19.84 | $56.05 |
Technical Indicators
Market Signals| Indicator | NMRK | VERA |
|---|---|---|
| Relative Strength Index (RSI) | 54.75 | 59.68 |
| Support Level | $15.34 | $40.87 |
| Resistance Level | $15.72 | $43.30 |
| Average True Range (ATR) | 0.47 | 2.62 |
| MACD | 0.07 | 0.37 |
| Stochastic Oscillator | 51.03 | 68.92 |
Price Performance
Historical ComparisonAbout NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.